UK Scientists Achieve Breakthrough in Slowing Huntington's Disease with Gene Therapy

Groundbreaking Gene Therapy for Huntington's Disease

• 💡 A new gene therapy, AMT-130, has shown promise in slowing the progression of Huntington's disease for the first time.
• 🎯 Early-stage trials involving 29 patients at University College London indicated that the condition progressed up to 75% slower over a three-year period.

Impact on Patients' Lives

• 🚀 The therapy aims to help individuals maintain their function longer, enabling them to stay in work, support families, and remain independent.
• 🧠 Huntington's disease is a rare, inherited brain disorder affecting movement, thinking, and mood, typically leading to death 10 to 30 years after symptom onset.
• ✅ One patient, Jack May Davis, shared that the treatment offers a brighter future and the prospect of having more time than initially anticipated.

Future Regulatory Steps

• 🔬 Uniure, the gene therapy company overseeing the study, plans to submit an application to US regulators for accelerated market approval of the drug by early next year.